Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Glenmark Pharmaceuticals Ltd. (GPL) is a global, research-driven pharmaceutical company headquartered in Mumbai, India. With a presence in over 80 countries, Glenmark is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). The company has a significant presence in branded generics, specialty, and OTC businesses, focusing on therapeutic areas like respiratory, dermatology, and oncology. Glenmark is committed to enriching lives through innovative and affordable medicines, supported by its state-of-the-art manufacturing and R&D facilities across the globe.
The Mumbai headquarters serves as the central command for Glenmark's global operations, including strategic planning, corporate governance, research and development oversight, and international business management.
Glenmark House is a modern corporate office designed to foster innovation and collaboration. It likely incorporates advanced communication technologies, meeting spaces, and facilities that support its diverse global workforce and R&D focus.
The work culture at Glenmark's HQ is characterized by a focus on innovation, patient-centricity, integrity, and respect. It promotes a dynamic environment that encourages learning, growth, and cross-functional collaboration to achieve its mission of discovering and delivering novel medicines.
As the birthplace and primary operational base, the Mumbai headquarters is pivotal to Glenmark's identity and global strategy. It directs the company's expansion, R&D pipeline, and its commitment to providing healthcare solutions worldwide.
Glenmark Pharmaceuticals has a robust global footprint, operating in over 80 countries. Its worldwide functions include comprehensive research and development of NCEs and NBEs, manufacturing of APIs and finished dosage forms from 17 facilities across India, USA, Argentina, and Czech Republic. The company also handles global marketing, sales, and distribution of its diverse portfolio of branded generics, specialty products, and over-the-counter medicines, with key R&D centers in India, Switzerland, and the USA.
Glenmark House, B. D. Sawant Marg, Chakala, Andheri (East)
Mumbai
Maharashtra
India
Address: 750 Corporate Drive, Mahwah, NJ 07430, USA
To spearhead Glenmark's growth and presence in the United States, the world's largest pharmaceutical market, by launching new products and strengthening its portfolio in specialty and generic segments.
Address: Chemin de la Combeta 5, 2300 La Chaux-de-Fonds, Switzerland
Leverages Switzerland's advanced biotech ecosystem and research talent pool to drive innovation in Glenmark's pipeline, particularly in areas like oncology and immunology.
Address: UB2 5NE, Southall, United Kingdom (Address may vary, this is a general area for UK operations)
To ensure the availability of Glenmark's medicines in the UK and parts of Europe, navigating the local regulatory landscape and commercializing its portfolio effectively.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Glenmark Pharmaceuticals' leadership includes:
Glenmark Pharmaceuticals has been backed by several prominent investors over the years, including:
Glenmark Pharmaceuticals has strengthened its leadership team over the past year with strategic appointments, particularly enhancing its generics business operations and global human resources functions. Core top leadership positions, including the Chairman & Managing Director and Global CFO, have maintained stability.
Discover the tools Glenmark Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Glenmark Pharmaceuticals generally uses a consistent email format for its employees, which typically combines the employee's first and last name. This structure is common for professional communication within and outside the organization.
[first].[last]@glenmarkpharma.com
Format
john.doe@glenmarkpharma.com
Example
85%
Success rate
Business Standard • May 1, 2024
Glenmark Pharmaceuticals announced it has received final approval from the U.S. Food & Drug Administration (USFDA) for Saxagliptin Tablets, 2.5 mg and 5 mg. This product is a generic version of AstraZeneca’s Onglyza® Tablets and is prescribed for the treatment of type 2 diabetes mellitus....more
Glenmark Pharmaceuticals Official Website • April 25, 2024
Glenmark Pharmaceuticals reported that its innovative nasal spray, Ryaltris®, used for treating allergic rhinitis, is now accessible in 34 countries around the world. This expansion increases the availability of this novel treatment option for patients suffering from allergic rhinitis symptoms....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Glenmark Pharmaceuticals, are just a search away.